It showed high levels of accuracy at predicting death, major bleeding events and the need for blood transfusion. Visit Health Lab to read the full story. The BMC2 Probability of Events Following PCI application can be found here.

Researchers at Michigan Medicine developed an AI-driven algorithm that accurately predicts death and complications after PCI — which could emerge as a tool for clinicians as they determine treatment for blocked heart arteries.

Buying health care services directly online offers convenience but also risks if patients don’t tell their regular doctor or provider. Poll looks at older adults’ use and attitudes.

Researchers and clinicians at the U-M Health Frankel Cardiovascular Center began sending reconditioned pacemakers to low- and middle-income countries for compassionate use cases in 2010 through the “My Heart Your Heart” program.

A recent study from U-M offers more insight into the underlying causes of EOE.

Recently approved by the Food and Drug Administration, Pluvicto is a radionuclide-labelled drug administered to patients showing promising results.

A team developed a new approach for combining microbiome data together while overcoming the noise introduced by the different techniques used in each study into a tool they dubbed MaLiAmPi (Maximum Likelihood Amplicon Pipeline).

U-M study shows accurate AI models improved diagnostic decisions, but biased models led to serious declines

Itaconate shows promise in reducing inflammation for several conditions

The device would be the first clinical-grade, diagnostic wrist-worn device for long term Afib monitoring. Visit Health Lab to read the full story.

Drugs approved for people with obesity or diabetes, such as Ozempic and Wegovy, can reduce risk for older adults; a new poll shows attitudes toward them